Comments
Solara Active Pharma Science on Monday announced the successful completion of the USFDA inspection at the multi-product manufacturing facility at Cuddalore with zero 483 inspectional observations.
The Cuddalore facility was established in 1991 and is equipped with appropriate infrastructure to include several independent production blocks and related packaging sections, it said in a release to the exchanges.
The site is inspected by various Regulatory Authorities, including the USFDA, MHRA, EDQM, WHO, PMDA, TGA, KFDA, and COFEPRIS. The current USFDA inspection at the facility was scheduled and completed between July 1 and July 5. The stock slipped 2.14 per cent at ₹435.90.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.